BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7807165)

  • 1. Variance of sensory threshold measurements: discrimination of feigners from trustworthy performers.
    Yarnitsky D; Sprecher E; Tamir A; Zaslansky R; Hemli JA
    J Neurol Sci; 1994 Sep; 125(2):186-9. PubMed ID: 7807165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NeuroQuick--a novel bedside test for small fiber neuropathy?
    Haussleiter IS; Richter H; Scherens A; Schwenkreis P; Tegenthoff M; Maier C
    Eur J Pain; 2008 Nov; 12(8):1000-7. PubMed ID: 18325802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detecting malingerers by means of response-sequence analysis.
    Linschoten MR; Harvey LO
    Percept Psychophys; 2004 Oct; 66(7):1190-201. PubMed ID: 15751475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The SIMS Screen for feigned mental disorders: the development of detection-based scales.
    Rogers R; Robinson EV; Gillard ND
    Behav Sci Law; 2014; 32(4):455-66. PubMed ID: 25060144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for feigning in a civil forensic setting.
    Alwes YR; Clark JA; Berry DT; Granacher RP
    J Clin Exp Neuropsychol; 2008 Feb; 30(2):133-40. PubMed ID: 18938665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current perception thresholds in ageing.
    Evans ER; Rendell MS; Bartek JP; Bamisedun O; Connor S; Giitter M
    Age Ageing; 1992 Jul; 21(4):273-9. PubMed ID: 1325105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative test for sensory hand symptoms based on mechanoreceptor-specific vibrotactile thresholds.
    Brammer AJ; Sutinen P; Das S; Pyykkö I; Toppila E; Starck J
    J Acoust Soc Am; 2010 Feb; 127(2):1146-55. PubMed ID: 20136235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinguishing Feigned From Sincere Performance in Psychophysical Pain Testing.
    Kucyi A; Scheinman A; Defrin R
    J Pain; 2015 Oct; 16(10):1044-53. PubMed ID: 26259781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skin denervation in type 2 diabetes: correlations with diabetic duration and functional impairments.
    Shun CT; Chang YC; Wu HP; Hsieh SC; Lin WM; Lin YH; Tai TY; Hsieh ST
    Brain; 2004 Jul; 127(Pt 7):1593-605. PubMed ID: 15128619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving the Detection of Feigned Knowledge Deficits in Defendants Adjudicated Incompetent to Stand Trial.
    Gottfried ED; Hudson BL; Vitacco MJ; Carbonell JL
    Assessment; 2017 Mar; 24(2):232-243. PubMed ID: 26423350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of feigned mental retardation using the new generation of malingering detection instruments: preliminary findings.
    Graue LO; Berry DT; Clark JA; Sollman MJ; Cardi M; Hopkins J; Werline D
    Clin Neuropsychol; 2007 Dec; 21(6):929-42. PubMed ID: 17886151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detecting coached feigning using the Test of Memory Malingering (TOMM) and the Structured Inventory of Malingered Symptomatology (SIMS).
    Jelicic M; Ceunen E; Peters MJ; Merckelbach H
    J Clin Psychol; 2011 Sep; 67(9):850-5. PubMed ID: 21503898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accuracy of weightbearing at three target levels during bilateral upright stance in patients with neuropathic feet and control subjects.
    Bohannon RW; Kelly CB
    Percept Mot Skills; 1991 Feb; 72(1):19-24. PubMed ID: 2038514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A technique to detect psychogenic sensory loss.
    Tegnér R
    J Neurol Neurosurg Psychiatry; 1988 Nov; 51(11):1455-6. PubMed ID: 3236023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetic peripheral neuropathy: how reliable is a homemade 1-g monofilament for screening?
    Bourcier ME; Ullal J; Parson HK; Dublin CB; Witherspoon CA; Ward SA; Vinik AI
    J Fam Pract; 2006 Jun; 55(6):505-8. PubMed ID: 16750065
    [No Abstract]   [Full Text] [Related]  

  • 16. [The significance of quantitative temperature sense thresholds in diagnosis of small fibrous sensory neuropathy in patients with type 2 diabetes].
    Yin HM; Feng W; Ding MP
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2015 Mar; 31(2):150-3. PubMed ID: 26248423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thermal thresholds predict painfulness of diabetic neuropathies.
    Krämer HH; Rolke R; Bickel A; Birklein F
    Diabetes Care; 2004 Oct; 27(10):2386-91. PubMed ID: 15451905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small-fiber neuropathy and the 3243A>G mutation in mitochondrial DNA.
    Henning F; Oey PL; Oerlemans WG; Wokke JH
    J Neurol; 2007 Sep; 254(9):1281-2. PubMed ID: 17410323
    [No Abstract]   [Full Text] [Related]  

  • 19. An Australian study on feigned mTBI using the Inventory of Problems - 29 (IOP-29), its Memory Module (IOP-M), and the Rey Fifteen Item Test (FIT).
    Gegner J; Erdodi LA; Giromini L; Viglione DJ; Bosi J; Brusadelli E
    Appl Neuropsychol Adult; 2022; 29(5):1221-1230. PubMed ID: 33403885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of feigned tactile sensory loss using a forced-choice test of tactile discrimination and other measures of tactile sensation.
    Greve KW; Love JM; Heinly MT; Doane BM; Uribe E; Joffe CL; Bianchini KJ
    J Occup Environ Med; 2005 Jul; 47(7):718-27. PubMed ID: 16010198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.